Cargando…

Novel Natural Inhibitors of CYP1A2 Identified by in Silico and in Vitro Screening

Inhibition of cytochrome P450 (CYP) is a major cause of herb–drug interactions. The CYP1A2 enzyme plays a major role in the metabolism of drugs in humans. Its broad substrate specificity, as well as its inhibition by a vast array of structurally diverse herbal active ingredients, has indicated the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ruixin, Hu, Liwei, Li, Haiyun, Su, Juan, Cao, Zhiwei, Zhang, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116189/ https://www.ncbi.nlm.nih.gov/pubmed/21686183 http://dx.doi.org/10.3390/ijms12053250

Ejemplares similares

Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro
por: Yim, Sung-Kun, et al.
Publicado: (2020)

Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors
por: Temml, Veronika, et al.
Publicado: (2023)

IspE Inhibitors Identified by a Combination of In Silico and In Vitro High-Throughput Screening
por: Tidten-Luksch, Naomi, et al.
Publicado: (2012)

Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study
por: Liu, Qi, et al.
Publicado: (2011)

In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer
por: Lin, Z. Ping, et al.
Publicado: (2021)

Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library
por: Pohler, Alexandra, et al.
Publicado: (2022)

Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches
por: Hwang, Jayeong, et al.
Publicado: (2021)

In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase †
por: Herrmann, Fabian C., et al.
Publicado: (2015)

Screening of selective histone deacetylase inhibitors by proteochemometric modeling
por: Wu, Dingfeng, et al.
Publicado: (2012)

Virtual screening and in silico design of novel inhibitors of bacterial lectins
por: Alán, Jan, et al.
Publicado: (2012)

In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma
por: Pessetto, Ziyan Y., et al.
Publicado: (2016)

In Vitro Screening to Identify Anti-Toxoplasma Compounds and In Silico Modeling for Bioactivities and Toxicity
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2019)

In Silico Screening Identifies a Novel Potential PARP1 Inhibitor Targeting Synthetic Lethality in Cancer Treatment
por: Li, Jian, et al.
Publicado: (2016)

Metabolic inhibition of meloxicam by specific CYP2C9 inhibitors in Cunninghamella blakesleeana NCIM 687: in silico and in vitro studies
por: Prasad, G. Shyam, et al.
Publicado: (2016)

Platyphylloside, a potential inhibitor from epicarp of B. aegyptiaca against CYP450 protein in T. rubrum – In vitro and in silico approaches
por: Abuthakir, Mohamed Hussain Syed, et al.
Publicado: (2022)

Kinase Inhibitors with Antiepileptic Properties Identified with a Novel in Vitro Screening Platform
por: Liu, Jing, et al.
Publicado: (2019)

In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase
por: Kant, Vishnu, et al.
Publicado: (2022)

Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens
por: Velikova, Nadya, et al.
Publicado: (2016)

In-Silico Identified New Natural Sortase A Inhibitors Disrupt S. aureus Biofilm Formation
por: Thappeta, Kishore Reddy Venkata, et al.
Publicado: (2020)

In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19
por: Wang, Shuo, et al.
Publicado: (2022)

An in silico–in vitro pipeline for drug cardiotoxicity screening identifies ionic pro‐arrhythmia mechanisms
por: Clark, Alexander P., et al.
Publicado: (2022)

In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I
por: Herrmann, Fabian C., et al.
Publicado: (2017)

Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum
por: Yuan, Yongze, et al.
Publicado: (2017)

Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches
por: Szilágyi, Katalin, et al.
Publicado: (2019)

In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors
por: Saeed, Mohamed E. M., et al.
Publicado: (2022)

In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus
por: Tietcheu Galani, Borris Rosnay, et al.
Publicado: (2021)

Combination of Virtual Screening Protocol by in Silico toward the Discovery of Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
por: Fu, Ying, et al.
Publicado: (2018)

In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
por: Spiegel, Maciej, et al.
Publicado: (2021)

In Silico Screening for Novel Leucine Aminopeptidase Inhibitors with 3,4-Dihydroisoquinoline Scaffold
por: Ziemska, Joanna, et al.
Publicado: (2020)

In Silico and In Vitro Screening of Natural Compounds as Broad-Spectrum β-Lactamase Inhibitors against Acinetobacter baumannii New Delhi Metallo-β-lactamase-1 (NDM-1)
por: Vasudevan, Aparna, et al.
Publicado: (2022)

Screening of Novel Bioactive Peptides from Goat Casein: In Silico to In Vitro Validation
por: Coscueta, Ezequiel R., et al.
Publicado: (2022)

Natural coumarins from Murraya paniculata as mixed-type inhibitors of cholinesterases: In vitro and in silico investigations
por: Khalid, Asaad, et al.
Publicado: (2023)

Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors
por: Osmaniye, Derya, et al.
Publicado: (2021)

In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor
por: Gholami, Asma, et al.
Publicado: (2023)

Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies
por: de Almeida, Raquel B. M., et al.
Publicado: (2023)

In Silico Screening and In Vitro Activity Measurement of Javamide Analogues as Potential p38 MAPK Inhibitors
por: Park, Jae B.
Publicado: (2017)

Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches
por: Shinde, Ranajit Nivrutti, et al.
Publicado: (2018)

Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches
por: Pang, Xiaocong, et al.
Publicado: (2018)

Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach
por: Rowaiye, Adekunle Babajide, et al.
Publicado: (2022)

In vitro and in silico determination of glutaminyl cyclase inhibitors
por: Tran, Phuong-Thao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4qodqs1eoguh4njdtj2porq6rc